| Stromal features are predictive of disease mortality in oral cancer patients D Marsh, K Suchak, KA Moutasim, S Vallath, C Hopper, W Jerjes, T Upile, ... The Journal of pathology 223 (4), 470-481, 2011 | 262 | 2011 |
| Betel‐derived alkaloid up‐regulates keratinocyte alphavbeta6 integrin expression and promotes oral submucous fibrosis KA Moutasim, V Jenei, K Sapienza, D Marsh, PH Weinreb, SM Violette, ... The Journal of pathology 223 (3), 366-377, 2011 | 89 | 2011 |
| Upregulation of Eps8 in oral squamous cell carcinoma promotes cell migration and invasion through integrin-dependent Rac1 activation LF Yap, V Jenei, CM Robinson, K Moutasim, TM Benn, SP Threadgold, ... Oncogene 28 (27), 2524-2534, 2009 | 85 | 2009 |
| Cell migration and invasion assays KA Moutasim, ML Nystrom, GJ Thomas Cancer cell culture, 333-343, 2011 | 61 | 2011 |
| Targeting the myofibroblastic cancer-associated fibroblast phenotype through inhibition of NOX4 CJ Hanley, M Mellone, K Ford, SM Thirdborough, T Mellows, SJ Frampton, ... JNCI: Journal of the National Cancer Institute 110 (1), 109-120, 2018 | 55 | 2018 |
| Induction of fibroblast senescence generates a non-fibrogenic myofibroblast phenotype that differentially impacts on cancer prognosis M Mellone, CJ Hanley, S Thirdborough, T Mellows, E Garcia, J Woo, ... Aging (Albany NY) 9 (1), 114, 2017 | 46 | 2017 |
| A comparison of primary oesophageal squamous epithelial cells with HET‐1A in organotypic culture TJ Underwood, MF Derouet, MJ White, F Noble, KA Moutasim, E Smith, ... Biology of the Cell 102 (12), 635-644, 2010 | 37 | 2010 |
| Association between miR-31-3p expression and cetuximab efficacy in patients with KRAS wild-type metastatic colorectal cancer: a post-hoc analysis of the New EPOC trial S Pugh, R Thiébaut, J Bridgewater, ML Grisoni, K Moutasim, F Rousseau, ... Oncotarget 8 (55), 93856, 2017 | 30 | 2017 |
| Orofacial presentations of sarcoidosis–a case series and review of the literature TWJ Poate, R Sharma, KA Moutasim, MP Escudier, S Warnakulasuriya British dental journal 205 (8), 437-442, 2008 | 25 | 2008 |
| In vitro effect of bisphosphonates on oral keratinocytes and fibroblasts NMH McLeod, KA Moutasim, PA Brennan, G Thomas, V Jenei Journal of Oral and Maxillofacial Surgery 72 (3), 503-509, 2014 | 22 | 2014 |
| Evaluating the effect of immune cells on the outcome of patients with mesothelioma SJ Chee, M Lopez, T Mellows, S Gankande, KA Moutasim, S Harris, ... British journal of cancer 117 (9), 1341-1348, 2017 | 20 | 2017 |
| A case of vulvovaginal gingival lichen planus in association with Good’s syndrome KA Moutasim, TWJ Poate, JF Setterfield, SJ Challacombe Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and …, 2008 | 20 | 2008 |
| Pro‐migratory and TGF‐β‐activating functions of αvβ6 integrin in pancreatic cancer are differentially regulated via an Eps8‐dependent GTPase switch J Tod, CJ Hanley, MR Morgan, M Rucka, T Mellows, MA Lopez, P Kiely, ... The Journal of pathology 243 (1), 37-50, 2017 | 17 | 2017 |
| Crowdsourcing for translational research: analysis of biomarker expression using cancer microarrays J Lawson, RJ Robinson-Vyas, JP McQuillan, A Paterson, S Christie, ... British journal of cancer 116 (2), 237-245, 2017 | 14 | 2017 |
| GLI1 confers profound phenotypic changes upon LNCaP prostate cancer cells that include the acquisition of a hormone independent state SK Nadendla, A Hazan, M Ward, LJ Harper, K Moutasim, LS Bianchi, ... PLoS One 6 (5), e20271, 2011 | 13 | 2011 |
| HPV, tumour metabolism and novel target identification in head and neck squamous cell carcinoma JC Fleming, J Woo, K Moutasim, M Mellone, SJ Frampton, A Mead, ... British journal of cancer 120 (3), 356-367, 2019 | 12 | 2019 |
| Assessment of nuclear ZEB2 as a biomarker for colorectal Cancer outcome and TNM risk stratification R Sreekumar, S Harris, K Moutasim, R DeMateos, A Patel, K Emo, ... JAMA network open 1 (6), e183115-e183115, 2018 | 9 | 2018 |
| Human papillomavirus testing in diagnostic head and neck histopathology KA Moutasim, M Robinson, S Thavaraj Diagnostic Histopathology 21 (2), 77-84, 2015 | 8 | 2015 |
| Breast cancer in patients with germline TP53 pathogenic variants have typical tumour characteristics: the Cohort study of TP53 carrier early onset breast cancer … K Packwood, G Martland, M Sommerlad, E Shaw, K Moutasim, G Thomas, ... The Journal of Pathology: Clinical Research 5 (3), 189-198, 2019 | 7 | 2019 |
| Suppression of Hedgehog signalling promotes pro‐tumourigenic integrin expression and function KA Moutasim, T Mellows, M Mellone, MA Lopez, J Tod, PC Kiely, ... The Journal of Pathology 233 (2), 196-208, 2014 | 7 | 2014 |
